{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T03:48:10Z","timestamp":1792986490011,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["30972613"],"award-info":[{"award-number":["30972613"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["31000083"],"award-info":[{"award-number":["31000083"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Major Special Program of National Science and Technology of China","award":["2008ZX10004-014"],"award-info":[{"award-number":["2008ZX10004-014"]}]},{"name":"Major Special Program of National Science and Technology of China","award":["2008ZX10004-015"],"award-info":[{"award-number":["2008ZX10004-015"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.imlet.2011.04.003","type":"journal-article","created":{"date-parts":[[2011,4,20]],"date-time":"2011-04-20T06:14:11Z","timestamp":1303280051000},"page":"156-160","source":"Crossref","is-referenced-by-count":18,"title":["Cross protection against lethal West Nile virus challenge in mice immunized with recombinant E protein domain III of Japanese encephalitis virus"],"prefix":"10.1016","volume":"138","author":[{"given":"Shi-Hua","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Qiang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Dong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Yu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E-De","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Feng","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2011.04.003_bib0005","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1172\/JCI21623","article-title":"West Nile virus: a growing concern?","volume":"113","author":"Gould","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.imlet.2011.04.003_bib0010","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1056\/NEJMo020128","article-title":"West Nile virus encephalitis","volume":"347","author":"Petersen","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.imlet.2011.04.003_bib0015","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.virol.2007.12.021","article-title":"Vero cell-derived inactivated West Nile (WN) vaccine induces protective immunity against lethal WN virus infection in mice and shows a facilitated neutralizing antibody response in mice previously immunized with Japanese encephalitis vaccine","volume":"374","author":"Lim","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.imlet.2011.04.003_bib0020","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.1016\/j.vaccine.2006.12.005","article-title":"West Nile virus: recent trends in diagnosis and vaccine development","volume":"25","author":"Dauphin","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2011.04.003_bib0025","first-page":"221","article-title":"Equine vaccine for West Nile virus","volume":"114","author":"Ng","year":"2003","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.imlet.2011.04.003_bib0030","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3201\/eid0909.030025","article-title":"DNA vaccine for West Nile virus infection in fish crows (Corvus ossifragus)","volume":"9","author":"Turell","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.imlet.2011.04.003_bib0035","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1128\/CVI.00249-07","article-title":"Comparative efficacies of three commercially available vaccines against West Nile virus (WNV) in a short-duration challenge trial involving an equine WNV encephalitis model","volume":"14","author":"Seino","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.imlet.2011.04.003_bib0040","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1086\/505121","article-title":"Clinical features in children hospitalized during the 2005 epidemic of Japanese encephalitis in Uttar Pradesh, India","volume":"43","author":"Kumar","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.imlet.2011.04.003_bib0045","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1212\/WNL.57.12.2313","article-title":"Persistent movement disorders following Japanese encephalitis","volume":"57","author":"Murgod","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.imlet.2011.04.003_bib0050","series-title":"Fields virology","first-page":"1043","article-title":"Flaviviruses","author":"Burke","year":"2001"},{"key":"10.1016\/j.imlet.2011.04.003_bib0055","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004263.pub2","article-title":"Vaccines for preventing Japanese encephalitis","volume":"18","author":"Schioler","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.imlet.2011.04.003_bib0060","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1586\/14787210.4.2.313","article-title":"Japanese encephalitis: development of new candidate vaccines","volume":"4","author":"Bharati","year":"2006","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.imlet.2011.04.003_bib0065","first-page":"941","article-title":"Protection of SA14-14-2 live attenuated Japanese encephalitis vaccine against the wild-type JE viruses","volume":"116","author":"Jia","year":"2003","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.imlet.2011.04.003_bib0070","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0140-6736(96)91075-2","article-title":"Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study","volume":"347","author":"Hennessy","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.imlet.2011.04.003_bib0075","unstructured":"WHO position paper, Japanese encephalitis vaccine, Wkly Epidemiol Rec 2006;81:331\u201340."},{"key":"10.1016\/j.imlet.2011.04.003_bib0080","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1128\/JVI.74.4.1742-1751.2000","article-title":"Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose\u2013response effectiveness and extended safety testing in rhesus monkeys","volume":"74","author":"Monath","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.imlet.2011.04.003_bib0085","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0264-410X(98)00487-3","volume":"17","author":"Monath","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2011.04.003_bib0090","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1128\/JVI.72.1.73-83.1998","article-title":"Phylogeny of the genus Flavivirus","volume":"72","author":"Kuno","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.imlet.2011.04.003_bib0095","first-page":"277","article-title":"Two-way cross-protection between West Nile and Japanese encephalitis viruses in bonnet macaques","volume":"36","author":"Goverdhan","year":"1992","journal-title":"Acta Virol"},{"key":"10.1016\/j.imlet.2011.04.003_bib0100","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3201\/eid0803.010238","article-title":"Immunization with heterologous flaviviruses protective against fatal West Nile encephalitis","volume":"8","author":"Tesh","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.imlet.2011.04.003_bib0105","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1016\/S0264-410X(03)00507-3","article-title":"Partial protective effect of inactivated Japanese encephalitis vaccine on lethal West Nile virus infection in mice","volume":"21","author":"Takasaki","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2011.04.003_bib0110","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1128\/JVI.65.10.5579-5583.1991","article-title":"The flavivirus envelope protein E: isolation of a soluble form from tick-borne encephalitis virus and its crystallization","volume":"65","author":"Heinz","year":"1991","journal-title":"J Virol"},{"key":"10.1016\/j.imlet.2011.04.003_bib0115","doi-asserted-by":"crossref","first-page":"11467","DOI":"10.1128\/JVI.01125-06","article-title":"Crystal structure of the West Nile virus envelope glycoprotein","volume":"80","author":"Nybakken","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.imlet.2011.04.003_bib0120","doi-asserted-by":"crossref","first-page":"12816","DOI":"10.1128\/JVI.00432-07","article-title":"Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes","volume":"81","author":"Sukupolvi-Petty","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.imlet.2011.04.003_bib0125","doi-asserted-by":"crossref","first-page":"13975","DOI":"10.1128\/JVI.78.24.13975-13986.2004","article-title":"Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes","volume":"78","author":"Crill","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.imlet.2011.04.003_bib0130","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.vaccine.2007.10.055","article-title":"Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus","volume":"26","author":"Martina","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2011.04.003_bib0135","first-page":"1218","article-title":"RNA elements within the 5\u2032 untranslated region of the West Nile virus genome are critical for RNA","volume":"91","author":"Li","year":"2010","journal-title":"Synth Virus Replication"},{"key":"10.1016\/j.imlet.2011.04.003_bib0140","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00430-007-0043-4","article-title":"Immunogenicity and protective eYcacy of the E. coli-expressed domain III of Japanese encephalitis virus envelope protein in mice","volume":"196","author":"Alka","year":"2007","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.imlet.2011.04.003_bib0145","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1586\/14787210.3.6.931","article-title":"Development of effective therapies against West Nile virus infection","volume":"3","author":"Diamond","year":"2005","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"10.1016\/j.imlet.2011.04.003_bib0150","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0042-6822(91)90471-M","article-title":"Nucleotide changes responsible for loss of neuroinvasiveness in Japanese encephalitis virus neutralization-resistant mutants","volume":"181","author":"Cecilia","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.imlet.2011.04.003_bib0155","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/0264-410X(95)00097-K","article-title":"Finer mapping of neutralizing epitope(s) on the C-terminal of Japanese encephalitis virus E-protein expressed in recombinant Escherichia coli system","volume":"13","author":"Seif","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2011.04.003_bib0160","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0168-1702(97)00098-1","article-title":"Japanese encephalitis virus antigenic variants with characteristic differences in neutralization resistance and mouse virulence","volume":"51","author":"Wu","year":"1997","journal-title":"Virus Res"},{"key":"10.1016\/j.imlet.2011.04.003_bib0165","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.4049\/jimmunol.178.5.2699","article-title":"Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection","volume":"178","author":"Chu","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.imlet.2011.04.003_bib0170","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1016\/S0264-410X(03)00042-2","article-title":"The domain III fragment of Japanese encephalitis virus envelope protein: mouse immunogenicity and liposome adjuvanticity","volume":"21","author":"Wu","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2011.04.003_bib0175","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1128\/JVI.77.4.2600-2606.2003","article-title":"A functional epitope determinant on domain III of the Japanese encephalitis virus envelope protein interacted with neutralizing-antibody combining sites","volume":"77","author":"Lin","year":"2003","journal-title":"J Virol"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247811001192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247811001192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T11:43:28Z","timestamp":1592480608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247811001192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0165247811001192"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2011.04.003","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}